SEMA4C promotes oncogenic signaling in breast cancer, hepatocellular cancer, and osteosarcoma, it also regulates proliferation, migration, lymphangiogenesis, and metastasis of cancer cells [14, 16–18, 20, 22]. Here, SEMA4C is linked to osteosarcoma.